Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-12-403449
Filing Date
2012-09-25
Accepted
2012-09-25 17:02:28
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d415240ds3.htm S-3 218881
2 FORM OF SENIOR INDENTURE d415240dex42.htm EX-4.2 349578
3 FORM OF SUBORDINATED INDENTURE d415240dex43.htm EX-4.3 379384
4 OPINION OF ADAMS & REESE, LLP d415240dex51.htm EX-5.1 14342
5 STATEMENT OF COMPUTATION d415240dex121.htm EX-12.1 16966
6 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d415240dex231.htm EX-23.1 1641
  Complete submission text file 0001193125-12-403449.txt   981728
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-3 | Act: 33 | File No.: 333-184091 | Film No.: 121109479
SIC: 2834 Pharmaceutical Preparations